P

Inventor

LIN NAN-HORNG

US45 patents
⚠️ This page may combine multiple inventors who share the name “LIN NAN-HORNG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ABBOTT LAB

25 patents
US5278176AJan 11, 1994

Nicotine derivatives that enhance cognitive function

ABBOTT LAB137 citations98
US5948793ASep 7, 1999

3-pyridyloxymethyl heterocyclic ether compounds useful in controlling neurotransmitter release

ABBOTT LAB77 citations96
US5629325AMay 13, 1997

3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission

ABBOTT LAB106 citations96
US6437138B1Aug 20, 2002

3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission

ABBOTT LAB54 citations95
US5914328AJun 22, 1999

Heterocyclic ether compounds useful in controlling neurotransmitter release

ABBOTT LAB67 citations95
US5472958ADec 5, 1995

2-((nitro)phenoxymethyl) heterocyclic compounds that enhance cognitive function

ABBOTT LAB55 citations93
US6127386AOct 3, 2000

3-Pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission

ABBOTT LAB47 citations92
US5733912AMar 31, 1998

7A-heterocycle substituted hexahydro-1H-pyrrolizine compounds useful in controlling chemical synaptic transmission

ABBOTT LAB35 citations92
US5409946AApr 25, 1995

Isoxazole, isothiazole and pyrazole compounds that enhance cognitive function

ABBOTT LAB50 citations91
US6656958B2Dec 2, 2003

Substituted pyridine compounds useful for controlling chemical synaptic transmission

ABBOTT LAB13 citations84
US7456169B2Nov 25, 2008

Heterocyclic kinase inhibitors

ABBOTT LAB9 citations83
US6133253AOct 17, 2000

3-Pyridyl enantiomers and their use as analgesics

ABBOTT LAB12 citations72
US5508418AApr 16, 1996

Intermediates for the preparation of enantiomerically-pure-3-methyl-5-(1-C1-C3-alkyl)-2-pyrrolidinyl)isoxazole

ABBOTT LAB1 citations63
US7323570B2Jan 29, 2008

Farnesyltransferase inhibitors

ABBOTT LAB2 citations62
US7211595B2May 1, 2007

Farnesyltransferase inhibitors

ABBOTT LAB5 citations62
US7056925B2Jun 6, 2006

Urea kinase inhibitors

ABBOTT LAB2 citations62
US6797825B2Sep 28, 2004

Protein kinase inhibitors

ABBOTT LAB3 citations62
US6001849ADec 14, 1999

Furopyridine, thienopyridine pyrrolopyridine useful in controlling chemical synaptic transmission

ABBOTT LAB6 citations62
US7956185B2Jun 7, 2011

Cyclobut-3-ene-1,2,-dione inhibitors of polo-like kinases

ABBOTT LAB5 citations61
US6403575B1Jun 11, 2002

3-Pyridyl enantiomers and their use as analgesics

ABBOTT LAB3 citations61
US5424444AJun 13, 1995

Method of preparing enantiomerically-pure 3-methyl-5-(1-alkyl-2(S)-pyrrolidinyl) isoxazoles

ABBOTT LAB2 citations54
US5559242ASep 24, 1996

Method of preparing enantiomerically-pure 3-methyl-5-(1-alkyl-2(S)-pyrrolidinyl) isoxazoles

ABBOTT LAB0 citations52
US5516912AMay 14, 1996

Method of preparing enantiomerically-pure 3-methyl-5-(1-alkyl-2(s)-pyrrolidinyl)isoxazoles

ABBOTT LAB0 citations52
US7320986B2Jan 22, 2008

Fused tri and tetra-cyclic pyrazole kinase inhibitors

ABBOTT LAB0 citations40
US7163939B2Jan 16, 2007

Macrocyclic kinase inhibitors

ABBOTT LAB0 citations39

MILES INC

5 patents

CHO PHARMA INC

5 patents

BARBIER LINDSAY BURNS

4 patents

BIOMEA FUSION INC

2 patents

BURNS BARBIER LINDSAY

1 patent

PENNING THOMAS D

1 patent

DEV CT BIOTECHNOLOGY

1 patent

DEV CENTER BIOTECHNOLOGY

1 patent